![5'-Deoxy-5-fluoro-N-(pentyloxy)carbonyl]cytidine 2',3'-diacetate CAS 162204-20-8](/images/load_icon.gif){kind=icon}
![5'-Deoxy-5-fluoro-N-(pentyloxy)carbonyl]cytidine 2',3'-diacetate CAS 162204-20-8](/photo/pl170305046-5_deoxy_5_fluoro_n_pentyloxy_carbonyl_cytidine_2_3_diacetate_cas_162204_20_8.jpg)
Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 162204-20-8
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Aluminum Foil Bag, Drum
Delivery Time: 7-15 days
Payment Terms: T/T, L/C, D/A, Western Union
Supply Ability: TON
CAS NO:: |
162204-20-8 |
Appearance :: |
White Powder |
Molecular Formula:: |
C19H26FN3O8 |
Molecular Weight:: |
443.423 |
EINECS NO:: |
700-593-2 |
MDL NO:: |
MFCD07369303 |
CAS NO:: |
162204-20-8 |
Appearance :: |
White Powder |
Molecular Formula:: |
C19H26FN3O8 |
Molecular Weight:: |
443.423 |
EINECS NO:: |
700-593-2 |
MDL NO:: |
MFCD07369303 |
Product Description:
Product Name: 5'-Deoxy-5-fluoro-N-(pentyloxy)carbonyl]cytidine 2',3'-diacetate CAS NO:162204-20-8
Synonyms:
Cytidine,5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-, 2',3'-diacetate;
Chemical & Physical Properties:
Appearance :white powder
Assay :≥99.0%
Density:1.4g/cm3
Melting Point:100-102℃
5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine 2',3'-diacetate is a key intermediate for the synthesis of capecitabine. Capecitabine, produced by Roche ) Was developed. In April 1998, it was approved to be marketed in the United States under the trade name Xeloda. In 2000, it was approved for import by SFDA. The marketed dosage form is tablets.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.
